Beta-endorphin may induce r e s p i r a t o r y depression and bradycardia. Elevated hypoxanthine (BX) l e v e l i n corpus v i t r e u m humor (CVH) i n d i c a t e s hypoxia before death. We measured beta-endorphin i m u n o r e a c t i v i t y (BEI) i n CSF and HX i n CVll I n SIDS v i c t i m s (11. 27)
and 111 c o n t r o l i n f a n t s (11.12).
I n a p i l o t study we measured DEI i n CSF I n p l g l e t s where t h c l a r y n x r e f l e x was induced by amnonlum gas (n.4). DEI i n CSF was a l s o measured a f t e r b r a i n hypoxia i n pig1e:s (17.6).
The BE1 l e v e l s i n CSF d i v i d e d the SIDS v i c t i m s i n t o two subpopulations:
one h a l f w i t h undetectable l e v e l ~4 . 3 fmol/ml CSF, and the o t h e r h a l f w i t h h i g h l e v e l 247 fmol/ml CSF (range 160-400). A l l t h c SIDS v l c t l m s had elevated l e v e l s o f HX I n CVH 209 mikromol/l (range 53-419) compared w i t h the c o n t r o l s t h a t d l e d a sudden death (accidental, c a r d l a l o r z t r a n g l e d ) , whlch had 54 mlkromol/l (range 0-188). I n the subpopulatlon o f SIDS v l c t i m s w l t h elevated BE1 I n CSF, we found a p o s i t i v e c o r r e l a t i o n between BE1 I n CSF and I1X l e v e l s I n CirH ~~0 . 9 2 (pt0.001). I n the c o n t r o l i n f a n t s no c o r r e l a t i o n between 821 I n CSF and IIX i n CYH was found. I n p i g l e t s where the l a r y n x r e f l e x was c x c l t e d , wc found increased l c v c l s of DEI I n CSF h h l c h c o r r e l a t e d w l t h t h e d u r a t i o n o f the apneas r=O.C4 (p-0.16). I n t h c c o n t r o l p i g l e t s undetectable l e v e l s of DEI i n CSF was found Conclusion: I n SIDS v i c t l m s w l t h c l e v a t c d l e v e l s o f DEI i n CSF, the DEI c o r r e l a t e d w l t h IiX i n CVH. The l a r y n x r e f l e x lnduced apneas, lnduced BE1 increase I n CSF i n p l q l e t s . Introduction: rH-€PO has been studied as a new treatment reoime for the anemia of prematurity i n t w o multicentre studies In order to avoid re2 cell transfusion with its potential hazards. Methods: We randomly assigned 29 premature infants to 2 treatment schedules with rH-EPO or none, Infants in treatment group 1 I n = 8, mean 8 W 1 4 3 6 + 1-3 5 7 g, mean GA 3 1 w l received 7 0 IU rH-EPOlkgBWlw upto day 2 5 of life by subcutaneous injection Into thigh, those in treatment group 2 I n = 6, mean DW 1 2 8 4 + / -I 4 8 g, mean GA 31 w l 750 UllkgBWlw upto day 4 2 of lifo. those i n the control oroup I n = 15, mean BW 1327 +I-3 1 6 0. mean GA 3 0 w ) recoived no treetment. All Infants received supplemental iron orally from day 1 4 of life.
Mean number of packed red cell transfusions per patient during the s t l~d y period wero 1.4 units (controlsl. 1.6 units (70 IU groupl and 0.1 7 tlnils I 7 5 0 IU group1 Mean retlculocyte counts were at day 3 of lile were 10.1 + I -5 % lconlrolsl. 8.8 + 1-4.4 % I 7 5 IU group) and 8.2 + I . 6.5 % 1750 IU group). I n both tlle control end the 7 5 IU group mean reticulocytes count decreased during ohservation time to mean values between 3 end 4 %, while i t increased in the 750 IU group to a highest value of 10.6 +I-2.3 % in week 3 and stayed at a high level of 7 to 8 % until week 5. Mean absolute normocyte count fell in a logarithmic manner but values wero higher in both treatment groups. The biggest difference was observod in week 4 with a mean of 1 8 0 normocytes in the.750 IU group. 7 5 in tile 7 5 IU oroup and only 1G in the control group. Concluwon: Low dose rH-EPO showed no sufficient effect for the treatment of anemia of prematurity. High dose rH-EPO prevents the need for transfusion In preterm infants, stimulates endooenous generation of normovolaemic hypochrome erythrocytes and does not sliniulate other cell lines than the red cell line. 
u r p o s e o f t h i s s t u d y was t o a s s e s s t h e e x t e n t o f l n v o l m e n t o f r a s o n c o q e n c s i n o s t c o s a r c o m a . STUDY DESIGN:
Tumor s a m p l e s f r o m a s e r i e s of 5 3 p e d i a t r i c p a t i e n t s 
